Description

This CME/CE-certified activity focuses on treatment strategies for depressive symptoms in bipolar disorder. It helps mental health and primary care teams understand the risks and benefits of various treatment approaches.

Effective diagnosis and treatment of bipolar disorder is critical to optimizing patient outcomes. The duration of untreated illness is directly associated with greater symptom severity, poorer response to medication, and even suicide risk early in the course of the disorder.

This activity is part of a free series. All the activities help you effectively assess and treat bipolar disorder, depression, schizophrenia, and related conditions such as fatigue and cognitive dysfunction.

View the other activities in the series: Massachusetts General Hospital Colloquium: Common Challenges in the Treatment of Mood Disorders and Schizophrenia

Learning Objectives

By the end of this program, participants will be able to:

  • Demonstrate effective treatment strategies for depressive symptoms in bipolar disorder.
  • Summarize risks and benefits of treatments for bipolar depression.
  • Describe risk of metabolic syndrome in the treatment of bipolar disorder.

Target Audience

This program is intended for:

  • Psychiatrists
  • Psychologists
  • Primary Care, Internal, and Family Care Physicians
  • Nurses
  • Allied Healthcare Professionals

Faculty

  • Thomas P. Hackett, MD, Endowed Chair in Psychiatry at MGH,
    Director, Bipolar Clinic and Research Program,
    Associate Director, Depression Clinical and Research Program,
    Director, Training and Education, MGH Research Institute,
    Massachusetts General Hospital,
    Professor of Psychiatry, Harvard Medical School

Educational Support

This program has received support in the form of educational grants from the following companies:

  • Janssen Global Services, LLC
  • Sunovion Pharmaceuticals, Inc.
  • Takeda Pharmaceuticals International, Inc.

CME Information

Release Date: October 15, 2014
Expiration Date: October 15, 2017
Review Date: October 1, 2015 by Michael Hirsch, MD
Review Date: November 29, 2016 by Robert Althoff, MD

To receive credit for this activity, you must view the presentation and complete the pre test, post test, and evaluation.

CREDIT

TYPE

ACCREDITATION STATEMENT

DESIGNATION STATEMENT

1.00

AMA PRACategory
1 Credit
TM

This activity has been planned
and implemented in accordance
with the accreditation
requirements and policies of the
Accreditation Council for
Continuing Medical Education
(ACCME) through the joint
providership of McLean Hospital
and Massachusetts General
Hospital. McLean Hospital is
accredited by the ACCME to
provide continuing medical
education for physicians.

McLean Hospital designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

1.00

Psychologists CE Credit

The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.

This offering meets the criteria for 1.00 continuing education credit for psychologists.

1.00

self-claim

Other Professions

Other Providers can claim a Participation Certificate upon successful completion of this course.

Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credits TMassociated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credits TMmay or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.


Planners

Tristan L. Gorrindo, MD
Jane Pimental, MPH
Michael Hirsch, MD
Susan E. Sprich, PhD

Disclosure Information
In accord with the disclosure policy of McLean Hospital as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all relevant financial relationships with commercial interests of both themselves and their spouses/partners over the past 12 months, as defined below:

Commercial Interest
The ACCME defines a "commercial interest" as any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org.

Financial relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Relevant financial relationships
ACCME focuses on financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CME activity. ACCME has not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME defines "'relevant' financial relationships" as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.

Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.

The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of this activity) consumed by, or used on, patients:

Planner Disclosures

Michael Hirsch, MD
Honoraria for writing: UpToDate

Susan E. Sprich, PhD
Royalties: Oxford University Press (for co-authoring treatment manual and client workbook), Springer (for editing book)

Speaker Disclosures

The following speakers and/or their spouse/partner have reported a relevant financial relationship with a commercial interest.

Andrew A. Nierenberg, MD
Consultant: Abbott Laboratories, American Psychiatric Association, Appliance Computing Inc. (Mindsite), Basliea, Brain Cells, Inc., Brandeis University, Bristol Myers Squibb, Clintara, Corcept, Dey Pharmaceuticals, Dainippon Sumitomo (now Sunovion), Eli Lilly and Company, EpiQ, L.P./Mylan Inc., Forest, Genaissance, Genetech, GlaxoSmithKline, Hoffman LaRoche, Infomedic, Lundbeck, Janssen Pharmaceutica, Jazz Pharmaceuticals, Medavante, Merck, Methylation Sciences, Naurex, Novartis, PamLabs, Pfizer, PGx Health, Ridge Diagnostics Shire, Schering-Plough, Somerset, Sunovion, Takeda Pharmaceuticals, Targacept, and Teva;consulted through the MGH Clinical Trials Network and Institute (CTNI)forAstra Zeneca, Brain Cells, Inc, Dianippon Sumitomo/Sepracor, Johnson and Johnson, Labopharm, Merck, Methylation Science, Novartis, PGx Health, Shire, Schering-Plough, Targacept, Takeda/Lundbeck Pharmaceuticals

Grants/Research support: American Foundation for Suicide Prevention, AHRQ, Brain and Behavior Research Foundation, Bristol-Myers Squibb, Cederroth, Cephalon, Cyberonics, Elan, Eli Lilly, Forest, GlaxoSmithKline, Janssen Pharmaceutica, Lichtwer Pharma, Marriott Foundation, Mylan, NIMH, PamLabs, PCORI, Pfizer Pharmaceuticals, Shire, Stanley Foundation, Takeda, Wyeth-Ayerst

Honoraria: Belvoir Publishing, University of Texas Southwestern Dallas, Brandeis University, Bristol-Myers Squibb, Hillside Hospital, American Drug Utilization Review, American Society for Clinical Psychopharmacology, Baystate Medical Center, Columbia University, CRICO, Dartmouth Medical School, Health New England, Harold Grinspoon Charitable Foundation, IMEDEX, International Society for Bipolar Disorder, Israel Society for Biological Psychiatry, Johns Hopkins University, MJ Consulting, New York State, Medscape, MBL Publishing, MGH Psychiatry Academy, National Association of Continuing Education, Physicians Postgraduate Press, SUNY Buffalo, University of Wisconsin, University of Pisa, University of Michigan, University of Miami, University of Wisconsin at Madison, APSARD, ISBD, SciMed, Slack Publishing,Wolters Klower Publishing

Stock: Appliance Computing, Inc. (MindSite); Brain Cells, Inc., Medavante

Copyrights: Clinical Positive Affect Scale and the MGH Structured Clinical Interview for the Montgomery Asberg Depression Scale exclusively licensed to the MGH Clinical Trials Network and Institute (CTNI).

All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.


Hardware/Software Specifications

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration

Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements

Windows PC:500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh:Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit


Privacy Policy

Please clickhereto review our privacy policy.